Loading...
Not a good buy right now. NINE is showing short-term momentum (positive, expanding MACD) but is already pushing into near-term resistance (R1 0.638) with RSI(6) ~70.8 (stretched). With no Intellectia buy signals today, no fresh news catalyst, and fundamentals still pressured (revenue and gross margin down), an impatient buyer has poor immediate risk/reward at current pre-market levels (0.61). Best stance: HOLD/avoid new entry until price reclaims and holds above 0.64–0.70 on strength or pulls back closer to support (0.54).
Pre-market: 0.61 (-4.69%) while SP500 is -0.7% (relative weakness this morning). Momentum is improving: MACD histogram +0.0189 and expanding (bullish). However, RSI_6 is elevated at ~70.77, suggesting the stock is short-term extended. Moving averages are converging (trend not firmly established). Key levels: Pivot 0.543 (near-term support/decision level), S1 0.447, S2 0.388; Resistance R1 0.638 (near current), R2 0.697. Pattern-based projection provided: ~0.85% next day, ~1.2% next week, ~15.59% next month (skewed toward a longer swing rather than an immediate pop).
Intellectia Proprietary Trading Signals

Hedge funds are reportedly buying with the buying amount up ~361.59% QoQ (supportive sentiment/positioning). Options open interest is call-heavy (bullish skew). Earnings date is upcoming (2026-02-05 pre-market), which can act as a catalyst if results/guide surprise positively. Losses are narrowing YoY (net income and EPS improved from very weak levels).
with RSI elevated, increasing odds of a near-term pullback/rejection. Micro-cap size (~$23.93M) typically amplifies volatility into earnings.
Latest quarter: 2025/Q3. Revenue fell to ~$132.0M (-4.44% YoY), indicating top-line contraction. Net income improved to -$14.65M (loss narrowed, +44.41% YoY improvement), and EPS improved to -$0.35 (+34.62% YoY improvement). However, gross margin dropped to ~8.9% (-21.59% YoY), a clear negative trend that can limit any rally durability unless it stabilizes. Overall: improving loss profile, but weakening sales and margin are a headwind.
No analyst rating/price target change data was provided, so a recent trend summary cannot be confirmed. Wall Street pro/con view cannot be reliably assessed from the dataset. Other influential activity: insiders are neutral (no significant recent trend). No recent Congress trading data in the last 90 days.
